Why is it taking so long to find a cure for Type 1 Diabetes?
While the biggest obstacle is the science behind actually finding a cure, cost is also a major factor.
To Develop a new drug in Australia is costly and there is always a delay to get to market as it has to be tested and approved. Less than 1% of drug leads will ever come to market.
Anything that can not be patented will not be promoted and there is little money to test anything that can not be patented as the people who patent the drugs are normally the ones that pay for it to be tested.
Investors are not as interest in large pharmaceutical as they previously were.
We are still recovering from the recession here in Australia and pharmaceutical companies are merging, cutting back on research and development spending, and many are moving away from drug discovery. Other biotech companies are cutting staff or shutting down altogether.
Drug companies are often asked to undertake many studies involving large groups of patients over long periods of time to make sure the drug is safe and effectiveness. This costs money and time. Easing the restrictions could help bring new drugs to market more quickly but at what cost to the people who then take them and need to know they are safe.
A way forward could be to increase public support for drug discovery, and some of the costly initial steps could be outsourced to a drug development process in other countries like India and China.
There needs to be a way for natural products (cant be patented) to be tested extensively and made available for Type 1 Diabetes sufferers.